726 related articles for article (PubMed ID: 2160318)
41. Development of anaplastic changes in low-grade astrocytomas of childhood.
Dirks PB; Jay V; Becker LE; Drake JM; Humphreys RP; Hoffman HJ; Rutka JT
Neurosurgery; 1994 Jan; 34(1):68-78. PubMed ID: 8121571
[TBL] [Abstract][Full Text] [Related]
42. Supratentorial malignant glioma: an analysis of radiation therapy in 178 cases.
Shibamoto Y; Yamashita J; Takahashi M; Yamasaki T; Kikuchi H; Abe M
Radiother Oncol; 1990 May; 18(1):9-17. PubMed ID: 2163064
[TBL] [Abstract][Full Text] [Related]
43. National Cancer Institute (phase II) study of high-grade glioma treated with accelerated hyperfractionated radiation and iododeoxyuridine: results in anaplastic astrocytoma.
Sullivan FJ; Herscher LL; Cook JA; Smith J; Steinberg SM; Epstein AH; Oldfield EH; Goffman TE; Kinsella TJ; Mitchell JB
Int J Radiat Oncol Biol Phys; 1994 Oct; 30(3):583-90. PubMed ID: 7928489
[TBL] [Abstract][Full Text] [Related]
44. Radiochemotherapy of malignant glioma in adults. Clinical experiences.
Kortmann RD; Jeremic B; Weller M; Plasswilm L; Bamberg M
Strahlenther Onkol; 2003 Apr; 179(4):219-32. PubMed ID: 12707711
[TBL] [Abstract][Full Text] [Related]
45. [Association of 5-FU, CDDP and hypofractionated radiotherapy in recurrences of subtentorial astrocytomas and malignant gliomas in adults].
Bolla M; Vincent P; Benabid A; Mousseau M; de Rougemont J; Vrousos C; Kolodié H; Vincent F; Pasquier B
Bull Cancer Radiother; 1990; 77(1):53-9. PubMed ID: 8703542
[TBL] [Abstract][Full Text] [Related]
46. Necrosis as a prognostic criterion in malignant supratentorial, astrocytic gliomas.
Nelson JS; Tsukada Y; Schoenfeld D; Fulling K; Lamarche J; Peress N
Cancer; 1983 Aug; 52(3):550-4. PubMed ID: 6305479
[TBL] [Abstract][Full Text] [Related]
47. A sequential chemo-radiotherapeutic treatment for patients with malignant gliomas: a phase II pilot study.
Dazzi C; Cariello A; Giannini M; Del Duca M; Giovanis P; Fiorentini G; Leoni M; Rosti G; Turci D; Tienghi A; Vertogen B; Zumaglini F; De Giorgi U; Marangolo M
Anticancer Res; 2000; 20(1B):515-8. PubMed ID: 10769716
[TBL] [Abstract][Full Text] [Related]
48. Spinal cord stimulation as adjuvant during chemotherapy and reirradiation treatment of recurrent high-grade gliomas.
Clavo B; Robaina F; Jorge IJ; Cabrera R; Ruiz-Egea E; Szolna A; Otermin E; Llontop P; Carames MA; Santana-Rodríguez N; Sminia P
Integr Cancer Ther; 2014 Nov; 13(6):513-9. PubMed ID: 25228535
[TBL] [Abstract][Full Text] [Related]
49. Combined modality approach to treatment of malignant gliomas--re-evaluation of RTOG 7401/ECOG 1374 with long-term follow-up: a joint study of the Radiation Therapy Oncology Group and the Eastern Cooperative Oncology Group.
Nelson DF; Diener-West M; Horton J; Chang CH; Schoenfeld D; Nelson JS
NCI Monogr; 1988; (6):279-84. PubMed ID: 3281031
[TBL] [Abstract][Full Text] [Related]
50. Retreatment of intracranial gliomas.
Landy HJ; Feun L; Schwade JG; Snodgrass S; Lu Y; Gutman F
South Med J; 1994 Feb; 87(2):211-4. PubMed ID: 8115886
[TBL] [Abstract][Full Text] [Related]
51. Proliferative potential and outcome in pediatric astrocytic tumors.
Prados MD; Krouwer HG; Edwards MS; Cogen PH; Davis RL; Hoshino T
J Neurooncol; 1992 Jul; 13(3):277-82. PubMed ID: 1325544
[TBL] [Abstract][Full Text] [Related]
52. Survival results from a phase I study of etanidazole (SR2508) and radiotherapy in patients with malignant glioma.
Chang EL; Loeffler JS; Riese NE; Wen PY; Alexander E; Black PM; Coleman CN
Int J Radiat Oncol Biol Phys; 1998 Jan; 40(1):65-70. PubMed ID: 9422559
[TBL] [Abstract][Full Text] [Related]
53. Radical surgery and reoperation in supratentorial malignant glial tumors.
Daneyemez M; Gezen F; Canakçi Z; Kahraman S
Minim Invasive Neurosurg; 1998 Dec; 41(4):209-13. PubMed ID: 9932265
[TBL] [Abstract][Full Text] [Related]
54. Changing incidence and improved survival of gliomas.
Ho VK; Reijneveld JC; Enting RH; Bienfait HP; Robe P; Baumert BG; Visser O;
Eur J Cancer; 2014 Sep; 50(13):2309-18. PubMed ID: 24972545
[TBL] [Abstract][Full Text] [Related]
55. Phase II trial of murine (131)I-labeled antitenascin monoclonal antibody 81C6 administered into surgically created resection cavities of patients with newly diagnosed malignant gliomas.
Reardon DA; Akabani G; Coleman RE; Friedman AH; Friedman HS; Herndon JE; Cokgor I; McLendon RE; Pegram CN; Provenzale JM; Quinn JA; Rich JN; Regalado LV; Sampson JH; Shafman TD; Wikstrand CJ; Wong TZ; Zhao XG; Zalutsky MR; Bigner DD
J Clin Oncol; 2002 Mar; 20(5):1389-97. PubMed ID: 11870184
[TBL] [Abstract][Full Text] [Related]
56. Pineal tumors: experience with 48 cases over 10 years.
Cho BK; Wang KC; Nam DH; Kim DG; Jung HW; Kim HJ; Han DH; Choi KS
Childs Nerv Syst; 1998; 14(1-2):53-8. PubMed ID: 9548342
[TBL] [Abstract][Full Text] [Related]
57. [HIT-GBM: multicenter study of treatment of children with malignant glioma].
Wolff JE; Boos J; Kühl J
Klin Padiatr; 1996; 208(4):193-6. PubMed ID: 8926684
[TBL] [Abstract][Full Text] [Related]
58. Multimodality management of recurrent adult malignant gliomas: results of a phase II multiagent chemotherapy study and analysis of cytoreductive surgery.
Rostomily RC; Spence AM; Duong D; McCormick K; Bland M; Berger MS
Neurosurgery; 1994 Sep; 35(3):378-88; discussion 388. PubMed ID: 7800129
[TBL] [Abstract][Full Text] [Related]
59. Stereotactic radiosurgery for glial neoplasms of childhood.
Grabb PA; Lunsford LD; Albright AL; Kondziolka D; Flickinger JC
Neurosurgery; 1996 Apr; 38(4):696-701; discussion 701-2. PubMed ID: 8692387
[TBL] [Abstract][Full Text] [Related]
60. [Synchronization chemoradiotherapy for malignant gliomas].
Yamamoto H; Sato F; Nakamura O; Kohno T; Shitara N; Takakura K; Sano K; Maehara T; Akanuma A
No Shinkei Geka; 1984 Jun; 12(7):795-805. PubMed ID: 6592471
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
